Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for AC Immune (ACIU) over the last 12 years, with Q3 2025 value amounting to $72.3 million.

  • AC Immune's Non-Current Assets rose 1060.55% to $72.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.3 million, marking a year-over-year increase of 1060.55%. This contributed to the annual value of $67.3 million for FY2024, which is 9989.65% down from last year.
  • As of Q3 2025, AC Immune's Non-Current Assets stood at $72.3 million, which was up 1060.55% from $70.6 million recorded in Q2 2025.
  • AC Immune's Non-Current Assets' 5-year high stood at $65.0 billion during Q4 2023, with a 5-year trough of $8.7 million in Q3 2021.
  • For the 5-year period, AC Immune's Non-Current Assets averaged around $7.7 billion, with its median value being $65.4 million (2024).
  • As far as peak fluctuations go, AC Immune's Non-Current Assets soared by 82677209.33% in 2021, and later tumbled by 9990.59% in 2022.
  • Quarter analysis of 5 years shows AC Immune's Non-Current Assets stood at $63.8 billion in 2021, then tumbled by 99.91% to $60.0 million in 2022, then soared by 108162.46% to $65.0 billion in 2023, then crashed by 99.9% to $67.3 million in 2024, then rose by 7.54% to $72.3 million in 2025.
  • Its Non-Current Assets was $72.3 million in Q3 2025, compared to $70.6 million in Q2 2025 and $65.6 million in Q1 2025.